Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 559

1.

PERL in Diabetes Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.

Afkarian M, Polsky S, Parsa A, Aronson R, Caramori ML, Cherney DZ, Crandall JP, de Boer IH, Elliott TG, Galecki AT, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Lingvay I, Maahs DM, McGill JB, Molitch ME, Perkins BA, Pop-Busui R, Pragnell M, Rosas SE, Rossing P, Senior P, Sigal RJ, Spino C, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M, Doria A; PERL Study Group.

Diabetes Care. 2019 Jun 11. pii: dc190342. doi: 10.2337/dc19-0342. [Epub ahead of print]

PMID:
31186299
2.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Jun 8. pii: dci190028. doi: 10.2337/dci19-0028. [Epub ahead of print]

PMID:
31177185
3.

Using Flash Continuous Glucose Monitoring in Primary Practice.

Hirsch IB, Wright EE Jr.

Clin Diabetes. 2019 Apr;37(2):150-161. doi: 10.2337/cd18-0054.

PMID:
31057221
4.

Evidence supports prediabetes treatment.

Neumiller JJ, Kalyani RR, Herman WH, Grant RW, Wysham CH, Inzucchi SE, Hirsch IB, Fonseca VA, Buse JB, Barrett EJ.

Science. 2019 Apr 26;364(6438):341-342. doi: 10.1126/science.aax3548. No abstract available.

PMID:
31023917
5.

Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5).

Ahmadi SS, Filipsson K, Dimenäs H, Isaksson SS, Imberg H, Sjöberg S, Ahrén B, Dahlqvist S, Gustafsson T, Tuomilehto J, Hirsch IB, Lind M.

Obes Sci Pract. 2019 Mar 18;5(2):130-140. doi: 10.1002/osp4.324. eCollection 2019 Apr.

6.

Hypoglycemia in People with Type 2 Diabetes and CKD.

Ahmad I, Zelnick LR, Batacchi Z, Robinson N, Dighe A, Manski-Nankervis JE, Furler J, O'Neal DN, Little R, Trence D, Hirsch IB, Bansal N, de Boer IH.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):844-853. doi: 10.2215/CJN.11650918. Epub 2019 Apr 17.

PMID:
30996047
7.

The Future of the GLP-1 Receptor Agonists.

Hirsch IB.

JAMA. 2019 Mar 23. doi: 10.1001/jama.2019.2941. [Epub ahead of print] No abstract available.

PMID:
30903797
8.

Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, Hirsch IB, McDonnell ME, Molitch ME, Murad MH, Sinclair AJ.

J Clin Endocrinol Metab. 2019 May 1;104(5):1520-1574. doi: 10.1210/jc.2019-00198.

PMID:
30903688
9.

Rates of Cardiac Rhythm Abnormalities in Patients with CKD and Diabetes.

Akoum N, Zelnick LR, de Boer IH, Hirsch IB, Trence D, Henry C, Robinson N, Bansal N.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):549-556. doi: 10.2215/CJN.09420818. Epub 2019 Mar 19.

PMID:
30890578
10.

Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma.

Chupp G, Lugogo NL, Kline JN, Ferguson GT, Hirsch I, Goldman M, Zangrilli JG, Trudo F.

Ann Allergy Asthma Immunol. 2019 May;122(5):478-485. doi: 10.1016/j.anai.2019.02.016. Epub 2019 Feb 23.

11.

Non-insulin treatments for Type 1 diabetes: critical appraisal of the available evidence and insight into future directions.

Wright LA, Hirsch IB.

Diabet Med. 2019 Jun;36(6):665-678. doi: 10.1111/dme.13941. Epub 2019 Mar 27. Review.

PMID:
30801765
12.

Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes.

Hirsch IB, Sherr JL, Hood KK.

Diabetes Care. 2019 Mar;42(3):345-348. doi: 10.2337/dci18-0040. No abstract available.

PMID:
30787056
13.

Self-Monitoring of Blood Glucose.

Garg SK, Hirsch IB.

Diabetes Technol Ther. 2019 Feb;21(S1):S4-S12. doi: 10.1089/dia.2019.2501. No abstract available.

PMID:
30785324
14.

Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma.

O'Quinn S, Xu X, Hirsch I.

J Asthma Allergy. 2019 Jan 23;12:21-33. doi: 10.2147/JAA.S190221. eCollection 2019.

15.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2019 Jan;25(1):69-100. doi: 10.4158/CS-2018-0535. Erratum in: Endocr Pract. 2019 Feb;25(2):204.

PMID:
30742570
16.

Ranting in 2019: Are Things Improving?

Hirsch IB.

Diabetes Technol Ther. 2019 Feb;21(2):59-61. doi: 10.1089/dia.2019.0004. Epub 2019 Jan 23. No abstract available.

PMID:
30672716
17.

Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes.

Wijkman MO, Dena M, Dahlqvist S, Sofizadeh S, Hirsch I, Tuomilehto J, Mårtensson J, Torffvit O, Imberg H, Saeed A, Lind M.

J Clin Hypertens (Greenwich). 2019 Jan;21(1):105-115. doi: 10.1111/jch.13447. Epub 2018 Dec 5.

18.

Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring.

Edelman SV, Argento NB, Pettus J, Hirsch IB.

Diabetes Care. 2018 Nov;41(11):2265-2274. doi: 10.2337/dc18-1150. Review.

PMID:
30348844
19.

Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines.

Peters AL, Ahmann AJ, Hirsch IB, Raymond JK.

J Endocr Soc. 2018 Oct 5;2(11):1214-1225. doi: 10.1210/js.2018-00262. eCollection 2018 Nov 1.

20.

Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study.

Onyango MA, Vian T, Hirsch I, Salvi DD, Laing R, Rockers PC, Ashigbie PG, Wirtz VJ.

PLoS One. 2018 Aug 24;13(8):e0201917. doi: 10.1371/journal.pone.0201917. eCollection 2018.

21.

Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma.

Bleecker ER, Wechsler ME, FitzGerald JM, Menzies-Gow A, Wu Y, Hirsch I, Goldman M, Newbold P, Zangrilli JG.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800936. doi: 10.1183/13993003.00936-2018. Print 2018 Oct.

22.

Brief Commentary: Confusing Treatment Guidelines for Patients With Type 2 Diabetes.

Hirsch IB, Skyler JS.

Ann Intern Med. 2018 Aug 21;169(4):253. doi: 10.7326/M18-1473. Epub 2018 Jun 26. No abstract available.

PMID:
29946704
23.

Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.

Beran D, Ewen M, Lipska K, Hirsch IB, Yudkin JS.

Curr Diab Rep. 2018 Jun 16;18(8):48. doi: 10.1007/s11892-018-1019-z. Review.

PMID:
29907884
24.

Erratum. Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective. Diabetes Care 2018;41:1125-1131.

Beran D, Hirsch IB, Yudkin JS.

Diabetes Care. 2018 Sep;41(9):2048. doi: 10.2337/dc18-er09a. Epub 2018 Jun 15. No abstract available.

25.

The Hybrid Closed-Loop System: Evolution and Practical Applications.

Weaver KW, Hirsch IB.

Diabetes Technol Ther. 2018 Jun;20(S2):S216-S223. doi: 10.1089/dia.2018.0091. Epub 2018 Jun 6.

PMID:
29873517
26.

Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective.

Beran D, Hirsch IB, Yudkin JS.

Diabetes Care. 2018 Jun;41(6):1125-1131. doi: 10.2337/dc17-2123. Erratum in: Diabetes Care. 2018 Jun 15;:.

PMID:
29784696
27.

Health Care Spending on Diabetes in the U.S., 1996-2013.

Squires E, Duber H, Campbell M, Cao J, Chapin A, Horst C, Li Z, Matyasz T, Reynolds A, Hirsch IB, Dieleman JL.

Diabetes Care. 2018 Jul;41(7):1423-1431. doi: 10.2337/dc17-1376. Epub 2018 May 10.

PMID:
29748431
28.

Clinically significant cognitive impairment in older adults with type 1 diabetes.

Chaytor NS, Barbosa-Leiker C, Ryan CM, Germine LT, Hirsch IB, Weinstock RS.

J Diabetes Complications. 2019 Jan;33(1):91-97. doi: 10.1016/j.jdiacomp.2018.04.003. Epub 2018 Apr 14.

PMID:
29728302
29.

Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes.

Runge AS, Kennedy L, Brown AS, Dove AE, Levine BJ, Koontz SP, Iyengar VS, Odeh SA, Close KL, Hirsch IB, Wood R.

Clin Diabetes. 2018 Apr;36(2):112-119. doi: 10.2337/cd17-0094.

30.

Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes.

Verrier ER, Yim SA, Heydmann L, El Saghire H, Bach C, Turon-Lagot V, Mailly L, Durand SC, Lucifora J, Durantel D, Pessaux P, Manel N, Hirsch I, Zeisel MB, Pochet N, Schuster C, Baumert TF.

Hepatology. 2018 Nov;68(5):1695-1709. doi: 10.1002/hep.30054. Epub 2018 Jul 10.

PMID:
29679386
31.

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).

Ólafsdóttir AF, Polonsky W, Bolinder J, Hirsch IB, Dahlqvist S, Wedel H, Nyström T, Wijkman M, Schwarcz E, Hellman J, Heise T, Lind M.

Diabetes Technol Ther. 2018 Apr;20(4):274-284. doi: 10.1089/dia.2017.0363. Epub 2018 Apr 2.

32.

Expression of TIM-3 on Plasmacytoid Dendritic Cells as a Predictive Biomarker of Decline in HIV-1 RNA Level during ART.

Font-Haro A, Janovec V, Hofman T, Machala L, Jilich D, Melkova Z, Weber J, Trejbalova K, Hirsch I.

Viruses. 2018 Mar 28;10(4). pii: E154. doi: 10.3390/v10040154.

33.

In Response to Carter and Heinemann: Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply Chain.

Petersen MP, Hirsch IB, Skyler JS, Ostlund RE, Cefalu WT.

J Diabetes Sci Technol. 2018 Jul;12(4):890-891. doi: 10.1177/1932296818761972. Epub 2018 Mar 16. No abstract available.

34.

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.

Janovec V, Aouar B, Font-Haro A, Hofman T, Trejbalova K, Weber J, Chaperot L, Plumas J, Olive D, Dubreuil P, Nunès JA, Stranska R, Hirsch I.

Front Immunol. 2018 Feb 26;9:364. doi: 10.3389/fimmu.2018.00364. eCollection 2018.

35.

Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3).

Dahlqvist S, Ahlén E, Filipsson K, Gustafsson T, Hirsch IB, Tuomilehto J, Imberg H, Ahrén B, Attvall S, Lind M.

BMJ Open Diabetes Res Care. 2018 Feb 24;6(1):e000464. doi: 10.1136/bmjdrc-2017-000464. eCollection 2018.

36.

DIABETES MANAGEMENT "UP IN THE AIR": IT'S TIME FOR CONSENSUS.

Trikudanathan S, Hirsch IB.

Endocr Pract. 2018 Jun;24(6):599-601. doi: 10.4158/EP-2017-0258. Epub 2018 Mar 2. No abstract available.

PMID:
29498917
37.

ONE-YEAR TIME ANALYSIS IN AN ACADEMIC DIABETES CLINIC: QUANTIFYING OUR BURDEN.

Huynh P, Toulouse A, Hirsch IB.

Endocr Pract. 2018 May;24(5):489-491. doi: 10.4158/EP-2017-0267. Epub 2018 Mar 2. No abstract available.

PMID:
29498912
38.

Diabetic Kidney Disease: Is There a Role for Glycemic Variability?

Subramanian S, Hirsch IB.

Curr Diab Rep. 2018 Feb 15;18(3):13. doi: 10.1007/s11892-018-0979-3. Review.

PMID:
29450720
39.

Self-Monitoring of Blood Glucose.

Garg SK, Hirsch IB.

Diabetes Technol Ther. 2018 Feb;20(S1):S3-S12. doi: 10.1089/dia.2018.2501. Review. No abstract available.

PMID:
29437471
40.

Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma.

Chipps BE, Newbold P, Hirsch I, Trudo F, Goldman M.

Ann Allergy Asthma Immunol. 2018 May;120(5):504-511.e4. doi: 10.1016/j.anai.2018.01.030. Epub 2018 Feb 1.

41.
42.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2018 Jan;24(1):91-120. doi: 10.4158/CS-2017-0153. Epub 2018 Jan 17.

PMID:
29368965
43.

Ranting in 2018: Are We Making Progress?

Hirsch IB.

Diabetes Technol Ther. 2018 Feb;20(2):91-93. doi: 10.1089/dia.2018.0004. No abstract available.

PMID:
29355434
44.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes.

Aleppo G, Laffel LM, Ahmann AJ, Hirsch IB, Kruger DF, Peters A, Weinstock RS, Harris DR.

J Endocr Soc. 2017 Nov 20;1(12):1445-1460. doi: 10.1210/js.2017-00388. eCollection 2017 Dec 1.

45.

Clinical Diabetes Centers of Excellence: A Model for Future Adult Diabetes Care.

Draznin B, Kahn PA, Wagner N, Hirsch IB, Korytkowski M, Harlan DM, McDonnell ME, Gabbay RA.

J Clin Endocrinol Metab. 2018 Mar 1;103(3):809-812. doi: 10.1210/jc.2017-02388.

PMID:
29309595
46.

Benign fibrous pseudotumor resulting in orchiectomy despite intraoperative frozen section.

Perez TY, O'Hara BJ, Hirsch IH.

Can J Urol. 2017 Dec;24(6):9132-9136.

PMID:
29260641
47.

Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data.

Garcia A, Balo AK, Buckingham BA, Hirsch IB, Peyser TA.

Diabetes Technol Ther. 2017 Dec;19(12):699-706. doi: 10.1089/dia.2017.0188.

PMID:
29243959
48.

Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data.

Peyser TA, Balo AK, Buckingham BA, Hirsch IB, Garcia A.

Diabetes Technol Ther. 2018 Jan;20(1):6-16. doi: 10.1089/dia.2017.0187. Epub 2017 Dec 11.

49.

AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.

Fonseca VA, Bloomgarden ZT, Dagogo-Jack S, Grunberger G, Einhorn D, Garber AJ, Handelsman Y, Hirsch IB, Umpierrez GE.

Endocr Pract. 2017 Nov;23(11):1345-1349. doi: 10.4158/EP-2017-0052.

PMID:
29190135
50.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

Supplemental Content

Loading ...
Support Center